<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110840">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01661101</url>
  </required_header>
  <id_info>
    <org_study_id>1160.143</org_study_id>
    <secondary_id>2011-006056-37</secondary_id>
    <nct_id>NCT01661101</nct_id>
  </id_info>
  <brief_title>Management of Myocardial Injury After Noncardiac Surgery Trial</brief_title>
  <acronym>MANAGE</acronym>
  <official_title>A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who have myocardial injury after noncardiac surgery are at a higher risk of dying
      than those who do not. One in 10 patients with myocardial injury will die within 30 days of
      surgery. This risk of death exists up to one year after myocardial injury. There are
      currently no treatments or guidelines available for heart injury after surgery, but there is
      evidence that taking a blood-thinner can prevent some of the deaths, both in the short and
      long-term. The purpose of this trial is to test the effect of two drugs (dabigatran and
      omeprazole) that may prevent mortality, major cardiovascular complications and major upper
      gastrointestinal bleeding in patients who have had myocardial injury after noncardiac
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myocardial injury is the most common major vascular complication after noncardiac surgery.
      Worldwide approximately 10 million adults annually suffer a perioperative myocardial injury.
      This figure for perioperative myocardial injury represents 15-20% of all cases of myocardial
      infarction in all settings. Myocardial injury after noncardiac surgery carries a poor
      prognosis and is an independent predictor of 30-day and 1-year mortality.

      Myocardial injury after noncardiac surgery (MINS) differs from non-operative myocardial
      infarction in two ways; it has a poorer prognosis (patients suffering MINS are 2 times more
      likely to die within 30 days compared to non-operative myocardial infarction in the
      emergency room) and paradoxically its treatment is less intensive. This difference in the
      intensity of treatment is likely influenced by several factors including: (1) a majority of
      patients suffering MINS do not experience ischemic symptoms, potentially influencing
      physicians' perception of the severity of the event; (2) there is debate as to the
      pathophysiology of MINS (although emerging evidence does suggest that coronary arterial
      thrombosis is an important mechanism of MINS); and (3) no randomized controlled trial (RCT)
      has evaluated an intervention to manage MINS, and hence physicians are uncertain about the
      risk-benefit ratio of potential interventions (e.g., interventions that are effective in the
      management of non-operative myocardial infarction). From a human and economic perspective,
      it is a tragedy that some patients undergoing noncardiac surgery for important reasons
      (e.g., to obtain a cure of their cancer or to become mobile after a new prosthetic joint)
      fail to obtain these benefits, because they suffer MINS that ultimately takes their life.
      There is an urgent need for clinical trials to identify effective therapies to improve the
      outcomes of patients suffering MINS.

      There exists promising laboratory, autopsy, imaging, operative, and non-operative data
      suggesting that patients suffering MINS will benefit from anticoagulant therapy. Dabigatran
      (a direct thrombin inhibitor) warrants evaluation in the management of MINS. The major
      limitation of anticoagulation therapy is bleeding, and gastrointestinal bleeding represents
      a substantial proportion of these complications. Gastrointestinal bleeding is important in
      its own right, but also because it leads to cessation of anticoagulant therapy which may
      lead to breakthrough myocardial infarction. Omeprazole (a proton pump inhibitor) is
      efficacious in preventing upper gastrointestinal bleeding in patients with coronary artery
      disease who are taking dual antiplatelet therapy, and may benefit patients receiving
      anticoagulation therapy after suffering MINS.

      We will undertake a large international RCT to determine the impact of dabigatran in
      patients who have suffered MINS. We will use a partial factorial design (for patients not
      taking a proton pump inhibitor) to determine the impact of omeprazole in this setting. We
      call this RCT the Management of myocardial injury After NoncArdiac surGEry (MANAGE) Trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major vascular complication (for Dabigatran)</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>A composite of the number of patients suffering vascular mortality, nonfatal myocardial infarction, nonfatal stroke, nonfatal peripheral arterial thrombosis, and nonfatal symptomatic pulmonary embolism.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major upper gastrointestinal complication (for Omeprazole)</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>A composite of the number of patients suffering overt gastroduodenal bleeding, overt upper gastrointestinal bleeding of unknown origin, or upper gastrointestinal perforation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Individual secondary outcomes for Dabigatran</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>The number of patients suffering all-cause mortality, vascular mortality, myocardial infarction, stroke, cardiac revascularization procedure, symptomatic venous thromboembolism (i.e., symptomatic pulmonary embolism or symptomatic deep venous thrombosis), amputation, peripheral arterial thrombosis, and rehospitalization for vascular reasons.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Upper gastrointestinal complication for Omeprazole</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>A composite of the number of patients suffering overt gastroduodenal bleeding, overt upper gastrointestinal bleeding of unknown origin, symptomatic gastroduodenal ulcer, gastrointestinal pain with underlying multiple gastroduodenal erosions, or upper gastrointestinal perforation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major vascular complication for Omeprazole</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>A composite of the number of patients suffering vascular mortality, nonfatal myocardial infarction, nonfatal stroke, nonfatal peripheral arterial thrombosis and nonfatal symptomatic pulmonary embolism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual secondary outcomes for Omeprazole</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>The number of patients suffering overt gastroduodenal bleeding, overt esophageal bleeding, overt upper gastrointestinal bleeding of unknown origin, symptomatic gastroduodenal ulcer, gastrointestinal pain with underlying multiple gastroduodenal erosions, upper gastrointestinal perforation, and bleeding of assumed occult gastrointestinal origin with a documented drop in hemoglobin of â‰¥ 3.0 g/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety outcomes for Dabigatran</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>The number of patients suffering life-threatening bleeding, major bleeding, intracranial bleeding, minor bleeding, significant lower gastrointestinal bleeding, non-significant lower gastrointestinal bleeding, and dyspepsia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety outcomes for Omeprazole</measure>
    <time_frame>Average of 1 year follow-up</time_frame>
    <description>The number of patients suffering Clostridium difficile-associated diarrhea, diarrhea, community-acquired pneumonia, and fractures.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">3200</enrollment>
  <condition>Myocardial Injury After Noncardiac Surgery (MINS)</condition>
  <arm_group>
    <arm_group_label>Dabigatran</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dabigatran 110 mg capsule taken twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Omeprazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Omeprazole 20 mg capsule taken once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (dabigatran)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dabigatran placebo taken twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (omeprazole)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Omeprazole placebo taken once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dabigatran</intervention_name>
    <description>Dabigatran 110 mg taken twice daily</description>
    <arm_group_label>Dabigatran</arm_group_label>
    <other_name>Pradaxa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Dabigatran)</intervention_name>
    <description>Dabigatran placebo taken twice daily</description>
    <arm_group_label>Placebo (dabigatran)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omeprazole</intervention_name>
    <description>Omeprazole 20 mg capsule taken once daily</description>
    <arm_group_label>Omeprazole</arm_group_label>
    <other_name>Prilosec</other_name>
    <other_name>Zegerid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for Omeprazole)</intervention_name>
    <description>Omeprazole placebo taken once daily</description>
    <arm_group_label>Placebo (omeprazole)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients are eligible if they:

          1. have undergone noncardiac surgery;

          2. are â‰¥45 years of age;

          3. have suffered MINS based upon fulfilling one of the following criteria: A. Elevated
             troponin or CK-MB measurement with one or more of the following defining features i.
             ischemic signs or symptoms (i.e., chest, arm, neck, or jaw discomfort; shortness of
             breath, pulmonary edema); ii. development of pathologic Q waves present in any two
             contiguous leads that are â‰¥30 milliseconds; iii. electrocardiogram (ECG) changes
             indicative of ischemia (i.e., ST segment elevation [â‰¥2 mm in leads V1, V2, or V3 OR
             â‰¥1 mm in the other leads], ST segment depression [â‰¥1 mm], OR symmetric inversion of T
             waves â‰¥1 mm) in at least two contiguous leads; iv. new LBBB; or v. new or presumed
             new cardiac wall motion abnormality on echocardiography or new or presumed new fixed
             defect on radionuclide imaging B. Elevated troponin measurement after surgery with no
             alternative explanation (e.g., pulmonary embolism, sepsis) to myocardial injury; AND

          4. provide written informed consent to participate within 35 days of suffering their
             MINS.

        Exclusion Criteria:

        Patients meeting any of the following criteria will be excluded:

          1. hypersensitivity or known allergy to dabigatran;

          2. history of intracranial, intraocular, or spinal bleeding;

          3. hemorrhagic disorder or bleeding diathesis;

          4. known hepatic impairment or liver disease expected to have an impact on survival;

          5. condition that requires therapeutic dose anticoagulation (e.g., prosthetic heart
             valve, venous thromboembolism, atrial fibrillation);

          6. currently using or plan to initiate rifampicin, cyclosporine, itraconazole,
             tacrolimus, ketoconazole, or dronedarone;

          7. women who are pregnant, breastfeeding, or of childbearing potential who refuse to use
             a medically acceptable form of contraception throughout the study;

          8. investigator considers the patient unreliable regarding requirement for study
             follow-up or study drug compliance; OR

          9. previously enrolled in the MANAGE Trial.

        Also excluded will be patients in whom any of the following criteria persist beyond 35
        days of their suffering MINS:

          1. the attending surgeon believes it is not safe to initiate therapeutic dose
             anticoagulation therapy;

          2. the attending physician believes ASA, intermittent pneumatic compression, or elastic
             stockings are not sufficient for venous thromboembolism (VTE) prophylaxis and that
             the patient requires a prophylactic-dose anticoagulant;

          3. the patient has an indwelling epidural or spinal catheter that cannot be removed, or
             the first dose of dabigatran will occur within 4 hours of epidural catheter removal;
             OR

          4. estimated glomerular filtration rate (eGFR) &lt;35 ml/min as estimated by calculated
             creatinine clearance.

          5. it is expected that the patient will undergo cardiac catheterization for MINS.

        Exclusion Criteria Specific to Patients in the Omeprazole Factorial Component of the
        Trial:

        Patients meeting any of the following criteria:

          1. hypersensitivity or known allergy to omeprazole;

          2. requirement for a proton pump inhibitor, an H2-receptor antagonist, sucralfate,
             atazanavir, clopidogrel, or misoprostol;

          3. esophageal or gastric variceal disease; OR

          4. patient declines participation in the omeprazole arm of MANAGE.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P.J. Devereaux, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Vincent, M.Sc.</last_name>
    <phone>905-527-4322</phone>
    <phone_ext>40635</phone_ext>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MANAGE Project Office</last_name>
    <email>manage@phri.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>North Florida/South Georgia Veterans Health System</name>
      <address>
        <city>Gainsville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Bavry, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>VA Western New York Healthcare System</name>
      <address>
        <city>Buffalo,</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamad Bourji</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabu Thomas, MD</last_name>
      <email>mailto:Sabu_Thomas@URMC.Rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Sabu Thomas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest School of Medicine</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Miller, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Gravenstein, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>VA Portland Health Centre</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Barrett</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Sacred Heart Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arturo Salazar, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Drexel University College of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Gupta, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>VA North Texas Health Care System Dallas VA Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto Cardiovascular de Buenos Aires</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>1428</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano Benzadon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Parra - Centro de Investigaciones</name>
      <address>
        <city>Rafaela</city>
        <state>Santa Fe</state>
        <zip>S2300MMA</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sanatorio San Martin</name>
      <address>
        <city>Venado Tuerto</city>
        <state>Santa Fe</state>
        <zip>2600</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oscar Gomez Vilamajo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Favaloro Foundation</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1093AAS</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital San Roque</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Parody, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy McCulloch, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead, NSW</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clara Chow, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Maternidade</name>
      <address>
        <city>PoÃ§os de Caldas</city>
        <state>Minas Gerais</state>
        <zip>50761160</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Bergo, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sociendade Hospitalar Angelina Caron</name>
      <address>
        <city>Campina Grande do Sul</city>
        <state>ParanÃ¡</state>
        <zip>83430</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dalton PrÃ©coma, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Lifecenter</name>
      <address>
        <city>Belo Horizonte</city>
        <zip>30110-921</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Estevao Figueiredo, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital FelÃ­cio Rocho - Av. ContorNo</name>
      <address>
        <city>Belo Horizonte</city>
        <zip>30110-934</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamil Saad, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital e Maternidade Celso Pierro - PUCCAMP</name>
      <address>
        <city>Campinas</city>
        <zip>13060-904</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JosÃ© Saraiva, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Barra D'Or</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>22775-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JoÃ£o Petriz, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Base</name>
      <address>
        <city>SÃ£o JosÃ© do Rio Preto</city>
        <zip>15090-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilia Maia, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto do CoraÃ§Ã£o do Triangulo Mineiro</name>
      <address>
        <city>UberlÃ¢ndia</city>
        <zip>38400-368</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Roberto Botelho, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2P4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Michael Jacka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Sciences Centre Winnipeg</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A1R9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sadeesh Srinathan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick Magloire, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John Neary, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juravinski Hospital and Cancer Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 4X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip J. Devereaux, MD</last_name>
      <phone>905-527-4322</phone>
      <phone_ext>40379</phone_ext>
      <email>philipj@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Vikas Tandon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ameen Patel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip J Devereaux, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queens University - Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7K2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Erb, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital, London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marko Mrkobrada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Victoria Hospital, London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6O 5R1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montreal - St. Luc Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2X3J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoit Deligne, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital - McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinica Foscal</name>
      <address>
        <city>Floridablanca</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo Parra Zuluaga, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liberec Regional Hospital</name>
      <address>
        <city>Liberec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucie FrancovÃ¡, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol</name>
      <address>
        <city>Motol</city>
        <zip>150 06</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr JanskÃ½, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava 8</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslav Homza, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bispebjerg Hospital, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Meyhoff, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan Isbye, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Meyhoff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nordsjaellands Hospital</name>
      <address>
        <city>HillerÃ¸d</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Koege-Roskilde Hospital</name>
      <address>
        <city>Koege</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ismail Gogenur, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vejle Hospital</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kristian Martinsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospice Civils de Lyon</name>
      <address>
        <city>Pierre Benite</city>
        <state>Lyon</state>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospitalier Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Coriat, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der J. W. Goethe-UniversitÃ¤t Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hesse</state>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UniversitÃ¤tsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mysore Medical College &amp; Research Institute</name>
      <address>
        <city>Mysore</city>
        <state>Karnataka</state>
        <zip>570001</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dinesha Basavanna, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amrita Institute of Medical Sciences and Research Institute</name>
      <address>
        <city>Kochi</city>
        <state>Kerala</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashok Bhaskaran Pillai, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. John's Medical College and Hospital</name>
      <address>
        <city>Bangalore</city>
        <zip>560034,</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S.G Subramanyam, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>M.S. Ramaiah Medical College &amp; Hospitals</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjay C Desai, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Narayana Hrudayalaya</name>
      <address>
        <city>Bengaluru</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robbie George, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institution of Medical Science and SUM Hospital,</name>
      <address>
        <city>Bhubaneswar</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suresh Kumar Behera, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>M.V. Hospital &amp; Research Centre</name>
      <address>
        <city>Lucknow</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjeev Mohan, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christian Medical College</name>
      <address>
        <city>Ludhiana</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Navneet Kumar Chaudhry, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rahate Surgical Hospital</name>
      <address>
        <city>Nagpur</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prashant Rahate, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ramana Maharishi Rangammal Hospital</name>
      <address>
        <city>Tiruvannamalai</city>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>T.R. Gurunath, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CMC Vellore</name>
      <address>
        <city>Vellore</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sant'Antonio Hospital</name>
      <address>
        <city>San Daniele Del Friuli</city>
        <state>Udine</state>
        <zip>33038</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucio Mos, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Niguarda Ca'Granda</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simonetta Passarani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Ortopedico Galeazzi Milan</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurizio Turiel</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele Scientific Institute</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Landoni, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aga Khan University Hospital - Nairobi</name>
      <address>
        <city>Nairobi</city>
        <zip>00508</zip>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Arzobispo Loayza</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Carrion, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Cayetano Heredia</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aida Rotta, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Docente de Trujillo</name>
      <address>
        <city>Trujillo</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caballero-Alvarado Jose, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>De La Salle University Medical Center</name>
      <address>
        <city>DasmariÃ±as City</city>
        <zip>4114</zip>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Philippines General Hospital</name>
      <address>
        <city>Manila</city>
        <zip>1000</zip>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>SPZOZ Szpital Powiatowy w Bochni</name>
      <address>
        <city>Bochnia</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaroslaw Gucwa, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spzoz w Brzesku</name>
      <address>
        <city>Brzesko</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pawel Dobosz, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Malopolskie Centrum Medyczne</name>
      <address>
        <city>Krakow</city>
        <zip>30-510</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wojciech Szczeklik, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OrtoMed sp. Z.o.o.</name>
      <address>
        <city>KrakÃ³w</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michal Slowiaczek, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny ZakÅ‚ad Opieki</name>
      <address>
        <city>KrakÃ³w</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Libura, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie</name>
      <address>
        <city>KrakÃ³w</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wojcich Mudyna, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szpital Å›w. Anny w Miechowie</name>
      <address>
        <city>MiechÃ³w</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan WÅ‚udarczyk, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spzoz w Myslenicach</name>
      <address>
        <city>Myslenice</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jakub Salwa, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZakÅ‚ad Opieki Zdrowotnej im. Jana PawÅ‚a II</name>
      <address>
        <city>WÅ‚oszczowa</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek GÃ³rka, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kwazulu-Natal</name>
      <address>
        <city>Congella</city>
        <state>Kwazulu-Natal</state>
        <zip>4013</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leanne Drummond, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grey's Hospital</name>
      <address>
        <city>Pietermaritzburg</city>
        <state>Kwazulu-Natal</state>
        <zip>3200</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reitze Rodseth, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of the Free State</name>
      <address>
        <city>Bloemfontein</city>
        <zip>9300</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Cape Town</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bongani Mayosi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bellvitge University Hospital</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marc Vives, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>8025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pilar Paniagua-Iglesias, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universatario Valle Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>8035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Miriam de Nadal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Serrano, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Belfast Health and Social Care Trust, Royal Victoria Hospital</name>
      <address>
        <city>Belfast</city>
        <state>North Ireland</state>
        <zip>BT12 6BA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Russell Halls Hospital, Dudley Group NHS</name>
      <address>
        <city>Dudley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Pierson, Dr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>India</country>
    <country>Italy</country>
    <country>Kenya</country>
    <country>Peru</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Israel</country>
    <country>Nigeria</country>
  </removed_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 7, 2016</lastchanged_date>
  <firstreceived_date>August 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Population Health Research Institute</investigator_affiliation>
    <investigator_full_name>P.J. Devereaux</investigator_full_name>
    <investigator_title>Professor, Medicine (Cardiology) and Clinical Epidemiology and Biostatistics, McMaster University</investigator_title>
  </responsible_party>
  <keyword>Perioperative myocardial infarction</keyword>
  <keyword>Myocardial injury</keyword>
  <keyword>noncardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dabigatran</mesh_term>
    <mesh_term>Omeprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
